Scandinavian Medical Solutions A/S (SMSMED.CO)
DKK 5.6
(-4.44%)
DKK 5.6
(-4.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -8.36 Million | -10.57 Million | 4.02 Million | 9.38 Million |
| Net Income | 16.62 Million | 14.74 Million | 10.87 Million | 4.51 Million |
| Depreciation & Amortization | 4.45 Million | 609.48 Thousand | 24.15 Thousand | 24.15 Thousand |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | -26.38 Million | -25.73 Million | -4.36 Million | 3.53 Million |
| Other non-cash items | -3.06 Million | -189.39 Thousand | -2.5 Million | 1.36 Million |
| Investing Cash Flow | -39.86 Million | -13.76 Million | -268.5 Thousand | -28.8 Thousand |
| Investments in PPE | -40.81 Million | -13.75 Million | - | - |
| Acquisitions | 1.24 Million | - | - | - |
| Investment purchases | -286.89 Thousand | -10.87 Thousand | -268.5 Thousand | -28.8 Thousand |
| Sales/Maturities of investments | -1.24 Million | - | - | - |
| Other Investing Activities | 1.24 Million | -10.87 Thousand | -268.5 Thousand | -28.8 Thousand |
| Financing Cash Flow | 21.18 Million | 26.7 Million | 11.07 Million | -2.76 Million |
| Debt repayment | -22.73 Million | - | - | - |
| Dividends payments | - | - | -4.51 Million | - |
| Common Stock Repurchased | - | - | - | -2.76 Million |
| Common Stock Issuance | 66.66 Thousand | 30 Million | 19.46 Million | -2.76 Million |
| Other Financing Activities | 43.85 Million | -3.29 Million | -3.87 Million | - |
| Accounts receivables | - | - | - | - |
| Accounts payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | -26.38 Million | -25.73 Million | -4.36 Million | 3.53 Million |
| Cash at beginning of period | 27.76 Million | 25.4 Million | 10.57 Million | 3.99 Million |
| Cash at end of period | 458.74 Thousand | 27.76 Million | 25.4 Million | 10.66 Million |
| Capital Expenditure | -40.81 Million | -13.75 Million | - | - |
| Effect of forex changes on cash | -258.35 Thousand | - | - | 3.99 Million |
| Net cash flow / Change in cash | -27.3 Million | 2.36 Million | 14.82 Million | 6.67 Million |
| Free Cash Flow | -49.18 Million | -24.32 Million | 4.02 Million | 9.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.31 Million | 1.31 Million | 2.73 Million | 16.62 Million | 1.36 Million | 9.48 Million |
| Depreciation & Amortization | 1.72 Million | 1.72 Million | 2.7 Million | 4.45 Million | 1.35 Million | 1.75 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.15 Million | -7.15 Million | -3.78 Million | -26.38 Million | -1.89 Million | -22.59 Million |
| Other non-cash items | -3.12 Million | -3.12 Million | 6.29 Million | -3.06 Million | 442.65 Thousand | 3.95 Million |
| Investing Cash Flow | -77 Thousand | -77 Thousand | -24.92 Million | -39.86 Million | -12.46 Million | -14.94 Million |
| Investments in PPE | -1.66 Million | -1.66 Million | -26.16 Million | -40.81 Million | -13.08 Million | -14.65 Million |
| Acquisitions | 3.2 Million | - | 1.24 Million | 1.24 Million | - | - |
| Investment purchases | -21 Thousand | - | - | -286.89 Thousand | - | -286.89 Thousand |
| Sales/Maturities of investments | - | - | - | -1.24 Million | - | - |
| Other Investing Activities | 1.59 Million | 1.59 Million | 620.4 Thousand | 1.24 Million | 620.4 Thousand | -143.5 Thousand |
| Financing Cash Flow | -570.5 Thousand | -570.5 Thousand | 21.39 Million | 21.18 Million | 10.69 Million | -210.1 Thousand |
| Debt repayment | -425 Thousand | - | - | -22.73 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 244 Thousand | - | - | 66.66 Thousand | - | 41.36 Thousand |
| Other Financing Activities | -570.5 Thousand | -570.5 Thousand | 10.69 Million | 43.85 Million | 10.69 Million | 5.02 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.15 Million | -7.15 Million | -1.89 Million | -26.38 Million | -1.89 Million | -11.29 Million |
| Cash at beginning of period | 7.91 Million | - | 1.7 Million | 27.76 Million | 1.7 Million | 27.76 Million |
| Cash at end of period | 6.13 Million | -7.85 Million | 7.91 Million | 458.74 Thousand | -622.85 Thousand | 1.7 Million |
| Capital Expenditure | -1.66 Million | -1.66 Million | -26.16 Million | -40.81 Million | -13.08 Million | -14.65 Million |
| Effect of forex changes on cash | 31.5 Thousand | 31.5 Thousand | -129.17 Thousand | -258.35 Thousand | -129.17 Thousand | - |
| Net cash flow / Change in cash | -1.78 Million | -7.85 Million | 6.21 Million | -27.3 Million | -2.32 Million | -26.05 Million |
| Free Cash Flow | -8.9 Million | -8.9 Million | -23.62 Million | -49.18 Million | -11.81 Million | -25.56 Million |
FMCXF
TIXT
PCTTW
600460
9933
CAST